ReviewTranslational lung cancer research2025

Mechanistic insights into the immune biomarker of perioperative immune checkpoint inhibitors for non-small cell lung cancer.

Yanting Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.